Search research articles
Contact Us
Filters
Showing results (41-50 of 130) with videos related to
Page
of 13
Sort By:
Life (Basel, Switzerland)
|
November 27, 2021
Biomechanical Performance of BoneHelix<sup>®</sup> Compared with Elastic Stable Intramedullary Nailing (ESIN) in a Pediatric Tibia Fracture Model
Laura Leonie Brandes, Luis Fernando Nicolini, Johannes Greven, et al.
Oncogene
|
September 19, 2003
Superoxide-dependent and -independent mitochondrial signaling during apoptosis in multiple myeloma cells
Dharminder Chauhan, Guilan Li, Martin Sattler, et al.
Cancer Research
|
October 16, 2003
c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions
Patrick C Ma, Takashi Kijima, Gautam Maulik, et al.
Oncotarget
|
January 5, 2018
Inhibition of SDF-1-induced migration of oncogene-driven myeloid leukemia by the L-RNA aptamer (Spiegelmer), NOX-A12, and potentiation of tyrosine kinase inhibition
Ellen L Weisberg, Martin Sattler, Abdel Kareem Azab, et al.
The Journal of Biological Chemistry
|
April 25, 2006
Activated Jak2 with the V617F point mutation promotes G1/S phase transition
Christoph Walz, Brian J Crowley, Heidi E Hudon, et al.
Oncotarget
|
March 23, 2011
Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders
Mayumi Naramura, Scott Nadeau, Bhopal Mohapatra, et al.
Blood
|
July 3, 2009
BCR-ABL promotes the frequency of mutagenic single-strand annealing DNA repair
Margret S Fernandes, Mamatha M Reddy, Jeffrey R Gonneville, et al.
Cancer Research
|
November 5, 2002
Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells
Takashi Kijima, Gautam Maulik, Patrick C Ma, et al.
Oncogene
|
February 22, 2002
Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells
Martin Sattler, Yuri B Pride, Laura R Quinnan, et al.
Cancer Research
|
October 20, 2004
Caveolin-1 is required for vascular endothelial growth factor-triggered multiple myeloma cell migration and is targeted by bortezomib
Klaus Podar, Reshma Shringarpure, Yu-Tzu Tai, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 130) with videos related to
Sort By:
Page
of 13
Life (Basel, Switzerland)
|
November 27, 2021
Biomechanical Performance of BoneHelix<sup>®</sup> Compared with Elastic Stable Intramedullary Nailing (ESIN) in a Pediatric Tibia Fracture Model
Laura Leonie Brandes, Luis Fernando Nicolini, Johannes Greven, et al.
Oncogene
|
September 19, 2003
Superoxide-dependent and -independent mitochondrial signaling during apoptosis in multiple myeloma cells
Dharminder Chauhan, Guilan Li, Martin Sattler, et al.
Cancer Research
|
October 16, 2003
c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions
Patrick C Ma, Takashi Kijima, Gautam Maulik, et al.
Oncotarget
|
January 5, 2018
Inhibition of SDF-1-induced migration of oncogene-driven myeloid leukemia by the L-RNA aptamer (Spiegelmer), NOX-A12, and potentiation of tyrosine kinase inhibition
Ellen L Weisberg, Martin Sattler, Abdel Kareem Azab, et al.
The Journal of Biological Chemistry
|
April 25, 2006
Activated Jak2 with the V617F point mutation promotes G1/S phase transition
Christoph Walz, Brian J Crowley, Heidi E Hudon, et al.
Oncotarget
|
March 23, 2011
Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders
Mayumi Naramura, Scott Nadeau, Bhopal Mohapatra, et al.
Blood
|
July 3, 2009
BCR-ABL promotes the frequency of mutagenic single-strand annealing DNA repair
Margret S Fernandes, Mamatha M Reddy, Jeffrey R Gonneville, et al.
Cancer Research
|
November 5, 2002
Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells
Takashi Kijima, Gautam Maulik, Patrick C Ma, et al.
Oncogene
|
February 22, 2002
Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells
Martin Sattler, Yuri B Pride, Laura R Quinnan, et al.
Cancer Research
|
October 20, 2004
Caveolin-1 is required for vascular endothelial growth factor-triggered multiple myeloma cell migration and is targeted by bortezomib
Klaus Podar, Reshma Shringarpure, Yu-Tzu Tai, et al.
Page
of 13